ArticleTherapeutic advances in respiratory disease

Antifibrotic therapy combined with pulmonary vasodilator therapy may improve survival in patients with pulmonary fibrosis and pulmonary hypertension: a retrospective cohort study.

Christian Cardillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.